Reuters logo
BRIEF-Shandong Xinhua Pharmaceutical posts HY net profit attributable of RMB106.8 mln
August 11, 2017 / 9:01 AM / 3 months ago

BRIEF-Shandong Xinhua Pharmaceutical posts HY net profit attributable of RMB106.8 mln

Aug 11 (Reuters) - Shandong Xinhua Pharmaceutical Co Ltd

* Board proposes no interim dividends be declared for first half year of 2017

* HY net profit attributable RMB106.8 million versus RMB 45.9 million

* HY total operating income RMB 2.40 billion, up 20.25 percent Source text (bit.ly/2vUFGZj) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below